The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

by Marius Trøseid, Geir Øystein Andersen, Kaspar Broch, Johannes Roksund Hov
Published 2020-02-01

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction

by Thor Ueland, Ola Kleveland, Rune Wiseth, Jan Kristian Damås, Pål Aukrust, Lars Gullestad, Kaspar Broch, Bjørn Bendz, Ingebjørg Seljeflot, Ragnhild Helseth, Annika Michelsen
Published 2021-06-01

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.

by Kaspar Broch, Erik T Askevold, Erik Gjertsen, Thor Ueland, Arne Yndestad, Kristin Godang, Wenche Stueflotten, Johanna Andreassen, Rolf Svendsmark, Hans-Jørgen Smith, Svend Aakhus, Pål Aukrust, Lars Gullestad
Published 2014-01-01

High-intensity interval training and health-related quality of life in de novo heart transplant recipients – results from a randomized controlled trial

by Katrine Rolid, Arne K. Andreassen, Marianne Yardley, Einar Gude, Elisabeth Bjørkelund, Anne R. Authen, Ingelin Grov, Kjell I. Pettersen, Christian H. Dall, Kristjan Karason, Kaspar Broch, Lars Gullestad, Kari Nytrøen
Published 2020-08-01

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy

by Aurelija Abraityte, Ida G. Lunde, Erik T. Askevold, Annika E. Michelsen, Geir Christensen, Pål Aukrust, Arne Yndestad, Arnt Fiane, Arne Andreassen, Svend Aakhus, Christen P. Dahl, Lars Gullestad, Kaspar Broch, Thor Ueland
Published 2017-06-01

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

by Cristiane C.K. Mayerhofer, Martin Kummen, Kristian Holm, Kaspar Broch, Ayodeji Awoyemi, Beate Vestad, Christopher Storm‐Larsen, Ingebjørg Seljeflot, Thor Ueland, Pavol Bohov, Rolf K. Berge, Asbjørn Svardal, Lars Gullestad, Arne Yndestad, Pål Aukrust, Johannes R. Hov, Marius Trøseid
Published 2020-04-01

A Middle-Aged Man Presenting With Progressive Heart Failure, Myopathy, and Monoclonal Gammopathy of Uncertain Significance

by Kaspar Broch, MD, PhD, Trine Popperud, MD, PhD, Einar Gude, MD, PhD, Yngvar Fløisand, MD, PhD, Ellen-Ann Antal, MD, PhD, Gerhard Bosse, MD, Christoffer Jonsrud, MD, PhD, Terje Hegard, MD, Silje Skaara, MD, Ahmed Elsais, MD, PhD
Published 2020-05-01

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial

by Ayodeji Awoyemi, Cristiane Mayerhofer, Alex S Felix, Johannes R Hov, Samuel D Moscavitch, Knut Tore Lappegård, Anders Hovland, Sigrun Halvorsen, Bente Halvorsen, Ida Gregersen, Asbjørn Svardal, Rolf K Berge, Simen H Hansen, Alexandra Götz, Kristian Holm, Pål Aukrust, Sissel Åkra, Ingebjørg Seljeflot, Svein Solheim, Andrea Lorenzo, Lars Gullestad, Marius Trøseid, Kaspar Broch
Published 2021-08-01